Wang W, Erbe AK, Alderson KA, Phillips E, Gallenberger M,Gan J, Campana D, Hank JA, Sondel PM. NK cells maintain licensing status and are subject to KIR/KIR-ligand inhibition following ex vivo expansion. Cancer Immunol Immunother. 2016 Sep;65(9):1047-59. - Stand Up To Cancer

Blog

Posted September 23, 2019

Wang W, Erbe AK, Alderson KA, Phillips E, Gallenberger M,Gan J, Campana D, Hank JA, Sondel PM. NK cells maintain licensing status and are subject to KIR/KIR-ligand inhibition following ex vivo expansion. Cancer Immunol Immunother. 2016 Sep;65(9):1047-59.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.